Overview
Hereditary elliptocytosis (HE), also known as hereditary ovalocytosis, is a group of inherited red blood cell membrane disorders characterized by the presence of elliptical (oval-shaped) erythrocytes on peripheral blood smear. The condition results from defects in proteins that form the red blood cell cytoskeleton, most commonly alpha-spectrin (SPTA1), beta-spectrin (SPTB), protein 4.1 (EPB41), or glycophorin C (GYPC). These structural protein abnormalities weaken the mechanical stability of the red blood cell membrane, causing the normally biconcave disc-shaped cells to become elongated and elliptical, particularly when subjected to shear stress in the circulation. The clinical spectrum of hereditary elliptocytosis is highly variable. The majority of affected individuals (approximately 90%) are asymptomatic carriers who are identified incidentally through a routine blood smear showing elliptocytes. However, a subset of patients may experience mild to moderate chronic hemolytic anemia with symptoms including fatigue, jaundice, splenomegaly, and gallstones. In rare cases, particularly in homozygous or compound heterozygous states, severe hemolytic anemia can occur, sometimes presenting in the neonatal period with significant jaundice and anemia requiring transfusion. A related severe variant, hereditary pyropoikilocytosis (HPP), is characterized by marked red cell fragmentation and severe hemolysis, often presenting in infancy. Treatment of hereditary elliptocytosis depends on clinical severity. Most patients require no treatment. For those with clinically significant hemolysis, folic acid supplementation is recommended to support increased red blood cell production. Splenectomy may be considered in patients with moderate to severe hemolytic anemia, as it can reduce the rate of red cell destruction and improve anemia, though it does not correct the underlying membrane defect. Neonatal cases may require phototherapy or exchange transfusion for hyperbilirubinemia. Genetic counseling is recommended for affected families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Hereditary elliptocytosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary elliptocytosis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary elliptocytosis.
Community
No community posts yet. Be the first to share your experience with Hereditary elliptocytosis.
Start the conversation →Latest news about Hereditary elliptocytosis
No recent news articles for Hereditary elliptocytosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary elliptocytosis
What is Hereditary elliptocytosis?
Hereditary elliptocytosis (HE), also known as hereditary ovalocytosis, is a group of inherited red blood cell membrane disorders characterized by the presence of elliptical (oval-shaped) erythrocytes on peripheral blood smear. The condition results from defects in proteins that form the red blood cell cytoskeleton, most commonly alpha-spectrin (SPTA1), beta-spectrin (SPTB), protein 4.1 (EPB41), or glycophorin C (GYPC). These structural protein abnormalities weaken the mechanical stability of the red blood cell membrane, causing the normally biconcave disc-shaped cells to become elongated and e
How is Hereditary elliptocytosis inherited?
Hereditary elliptocytosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Hereditary elliptocytosis?
3 specialists and care centers treating Hereditary elliptocytosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.